Managing anticoagulation in the COVID-19 era between lockdown and reopening phases
Open Access
- 1 August 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Internal and Emergency Medicine
- Vol. 15 (5), 783-786
- https://doi.org/10.1007/s11739-020-02391-3
Abstract
Patients on anticoagulant treatment are constantly increasing, with an estimated prevalence in Italy of 2% of the total population. The recent spreadout of the COVID-19 pandemic requires a re-organization of Anticoagulation Clinics to prevent person-to-person viral diffusion and continue to offer the highest possible quality of assistance to patients. In this paper, based on the Italian Federation of Anticoagulation Clinics statements, we offer some advice aimed at improving patient care during COVID-19 pandemic, with particular regard to the lockdown and reopening periods. We give practical guidance regarding the following points: (1) re-thinking the AC organization, (2) managing patients on anticoagulants when they become infected by the virus, (3) managing anticoagulation surveillance in non-infected patients during the lockdown period, and (4) organizing the activities during the reopening phases.This publication has 12 references indexed in Scilit:
- Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patientsInternal and Emergency Medicine, 2020
- Prominent changes in blood coagulation of patients with SARS-CoV-2 infectioncclm, 2020
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and FollowJournal of the American College of Cardiology, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 PandemicJournal of the American College of Cardiology, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- The effect of management models on thromboembolic and bleeding rates in anticoagulated patients: an ecological studyInternal and Emergency Medicine, 2019
- Extended International Normalized Ratio testing intervals for warfarin-treated patientsJournal of Thrombosis and Haemostasis, 2018
- Italian intersociety consensus on DOAC use in internal medicineInternal and Emergency Medicine, 2017
- Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized RatiosAnnals of Internal Medicine, 2011